Investment Details
Investor Type
Corporate VC
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Growth
Geographical Focus
Japan
Industries Focus
- Healthcare
- Consumer Goods
- Pharmaceuticals
Investor Details Founded: 2018
Saishunkan Co-Creation Laboratory is the corporate venture capital arm of Saishunkan Co., Ltd., a Japanese pharmaceutical company. The laboratory focuses on fostering innovation and co-creation by investing in and collaborating with startups and emerging companies. Its mission is to drive advancements in healthcare and related industries through strategic partnerships and investments.
The laboratory's investment strategy emphasizes early-stage and growth-stage companies, particularly those operating within Japan. It seeks to support ventures that align with Saishunkan's commitment to enhancing human health and well-being. By leveraging its expertise and resources, the laboratory aims to accelerate the development of innovative products and services.
Through its investments, Saishunkan Co-Creation Laboratory contributes to the growth of the Japanese healthcare sector, promoting the integration of new technologies and solutions that address evolving market needs. Its collaborative approach underscores the importance of partnerships in achieving sustainable innovation and societal impact.
Requirements
- Innovative healthcare solutions
- Alignment with Saishunkan's mission
- Potential for market impact in Japan
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Contact Number Hidden]
Portfolio Companies
- Saishunkan Pharmaceutical Co., Ltd.
Mentioned In
Claim this Investor
Are you an official representative of Saishunkan Co-Creation Laboratory?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim